Literature DB >> 30557295

Hippotherapy in Rehabilitation Care for Children With Neurological Impairments and Developmental Delays: A Case Series.

Kathryn A Kraft1, Janet Weisberg, Michael D Finch, Amanda Nickel, Kristen H Griffin, Timothy L Barnes.   

Abstract

PURPOSE: This report assesses functional mobility in children with neurological impairments and documented gross motor delays, before and after receiving either hippotherapy or standard outpatient physical therapy (PT). SUMMARY OF KEY POINTS: This is a case-series report using data previously collected for a discontinued randomized controlled trial, in which participants received hippotherapy or standard outpatient clinic PT for a 12-week treatment period. Results demonstrated both subjective and objective functional mobility improvements after treatment in participants receiving hippotherapy and standard outpatient PT, as determined by the Peabody Developmental Motor Scales-2, the Pediatric Evaluation of Disability Inventory, and the Goal Attainment Scaling. STATEMENT OF CONCLUSION AND RECOMMENDATIONS FOR CLINICAL PRACTICE:: When compared with standard outpatient PT, hippotherapy appears to be a viable treatment strategy for children aged 2 to 5 years with neurological impairments and gross motor delays, but additional research in this area is needed to validate findings.

Entities:  

Mesh:

Year:  2019        PMID: 30557295     DOI: 10.1097/PEP.0000000000000567

Source DB:  PubMed          Journal:  Pediatr Phys Ther        ISSN: 0898-5669            Impact factor:   3.049


  2 in total

1.  Specific and Non-specific Factors of Animal-Assisted Interventions Considered in Research: A Systematic Review.

Authors:  Cora Wagner; Carmina Grob; Karin Hediger
Journal:  Front Psychol       Date:  2022-06-28

2.  Pilot Study of the Influence of Equine Assisted Therapy on Physiological and Behavioral Parameters Related to Welfare of Horses and Patients.

Authors:  María Dolores Ayala; Andrea Carrillo; Pilar Iniesta; Pedro Ferrer
Journal:  Animals (Basel)       Date:  2021-12-10       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.